International
The Morning Science

What science found today

‹
 

Research

CAR T-cell therapy shows promise for patients with lupus

Medical Xpress ·

CAR T-cell therapy shows promise for patients with lupus

The Brief

  • Research presented at the annual meeting of the American College of Rheumatology (ACR Convergence) found CAR T-cell therapy is associated with consistent reductions in disease activity in patients with systemic lupus erythematosus.
  • The source reports the association as consistent across the findings presented, but the available excerpt does not give trial size, follow-up length or comparison groups.

Why it matters

Lupus is a chronic autoimmune disease with limited options for patients whose disease does not respond to standard treatment, so consistent reductions in disease activity from CAR T-cell therapy are a signal worth tracking for rheumatology and cell therapy research.

Who’s affected

  • patients with systemic lupus erythematosus
  • rheumatologists
  • researchers in cell therapy and autoimmune disease

For patients with systemic lupus erythematosus (SLE), chimeric antigen receptor T-cell (CAR T-cell) therapy is associated with consistent reductions in disease activity, according to research presented at the annual meeting of the American College of Rheumatology (ACR Convergence…

How do you feel about this?

0 Comments

    CAR T-cell therapy shows promise for patients with lupus – The Morning Science